WHITE PLAINS, N.Y., June 5 /PRNewswire/ -- CAD Sciences, the technology leader in MRI CAD for breast, prostate and other organs, was one of three CAD companies invited to participate in a conference sponsored by the U.K. Study Group on MRI Screening for Breast Cancer (MARIBS) held on May 25 at The Royal College of Radiology in London. The meeting was attended by a delegation of physicians and scientific luminaries from the United Kingdom whose primary goal was to make recommendations for optimal imaging protocols to be used when performing breast screening MR examinations. It offered the Company the ability not only to contribute to a panel discussion on the standard of care for women’s imaging but to frame the initial dialogue regarding the appropriate CAD system to be used for the evaluation of breast MRI. According to Andreas Muehler, M.D., President of CAD Sciences, “The invitation to the meeting confirms that CAD Sciences’ analysis algorithms are increasingly seen as an integral part of a comprehensive breast MRI procedure. The meeting also served as a great opportunity to convincingly present the advantages of CAD Sciences’ fTP technology over the limited capabilities of first generation breast MRI CAD systems.”
(Logo: http://www.newscom.com/cgi-bin/prnh/20060110/NYTU047LOGO )
About CAD Sciences:
Founded in March 2002, CAD Sciences is the technology leader in the advancement of computer-assisted modeling of contrast enhancement in MR imaging of cancer. From its base in White Plains, NY, the Company designs and internationally distributes certain intellectual property in CAD (Computer Assisted Diagnosis) and MRA (Magnetic Resonance Angiography) software for medical imaging. The Company’s Server2(TM) and WorkSpace(TM) software platforms are currently used by radiologist customers to facilitate the analysis, interventional planning and reporting of breast and prostate MRI. Together these products automate MRI image processing and provide higher quality imaging studies, lower facility costs, increased revenue streams for radiology practices as well as improved analysis and reporting tools for physicians. In addition, the Company is the sole distributor of Machnet breast biopsy intervention devices and magnetic resonance breast and carotid coils. More information about the Company or its technology can be obtained by visiting http://www.cadsciences.com or by calling our office at (877) 387-4387.
Release #45 Media Contacts: Raymond E. Joslin, (914) 313-0330, raymond.joslin@cadsciences.com Nancy Isenberger, (212) 818-1894, nancy.isenberger@cadsciences.com
Photo: http://www.newscom.com/cgi-bin/prnh/20060110/NYTU047LOGOCAD Sciences
CONTACT: Raymond E. Joslin, +1-914-313-0330,raymond.joslin@cadsciences.com, or Nancy Isenberger, +1-212-818-1894,nancy.isenberger@cadsciences.com, both of CAD Sciences
Web site: http://www.cadsciences.com/
